共 330 条
[1]
Denton CP(2017)Systemic sclerosis Lancet 390 1685-1699
[2]
Khanna D(2018)Mortality and survival in systemic sclerosis: a review of recent literature Curr Opin Rheumatol 30 588-593
[3]
Poudel DR(2021)Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink Rheumatology (Oxford) 60 2688-2696
[4]
Derk CT(2013)Autoantibodies in systemic sclerosis Autoimmun Rev 12 340-354
[5]
Pauling JD(2015)A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort New Zealand Clin Rheumatol 34 1921-1927
[6]
McGrogan A(2009)Anti-topoisomerase I autoantibodies in systemic sclerosis Autoimmun Rev 8 692-696
[7]
Snowball J(2013)2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative Ann Rheum Dis 72 1747-1755
[8]
McHugh NJ(2022)Epidemiology and clinical characteristics of systemic sclerosis overlap syndrome (SSc-OS), and the factors significantly associated with SSc-OS in Thai patients with systemic sclerosis Mod Rheumatol 32 899-907
[9]
Mehra S(2011)Interstitial lung disease in systemic sclerosis Autoimmun Rev 10 248-255
[10]
Walker J(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-S54